In situ-forming PLGA implants loaded with leuprolide acetate/-cyclodextrin complexes: mathematical modelling and degradation

被引:11
作者
Rahimi, Mehdi [1 ]
Mobedi, Hamid [2 ]
Behnamghader, Aliasghar [3 ]
机构
[1] Islamic Azad Univ, Sci & Res Branch, Dept Biomed Engn, Tehran, Iran
[2] Iran Polymer & Petrochem Inst, Dept Novel Drug Delivery Syst, POB 14965-115, Tehran, Iran
[3] Mat & Energy Res Ctr, Biomat Grp, Tehran, Iran
关键词
In situ-forming implant; PLGA; leuprolide acetate; -cyclodextrin complexes; mathematical modelling; degradation; CONTROLLED DRUG-DELIVERY; DISSOLUTION PROFILES; SOLUTE RELEASE; MICROSPHERES; KINETICS; ENDOMETRIOSIS; LEUPRORELIN; ABSORPTION; POLYMERS; TABLETS;
D O I
10.1080/02652048.2016.1194905
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Drug release mechanism of in situ-forming implants (ISIs) based on poly(lactic acid-co-glycolic acid) (PLGA) loaded with leuprolide acetate/-cyclodextrin (LA/-CD) complexes via fitting with four diffusion-based semi-empirical models were studied. The release rate constants and release exponent of ISIs were calculated. The main drug release mechanism was Fickian diffusion. The LA diffusion coefficient and release constant were decreased via increasing the portion of -CD in complexes. The release curve was parabolic, with a higher initial slope and then consistent with the exponential. All ISIs containing LA/-CD complexes better fitted with the Korsmeyer-Peppas, Weibull and Peppas-Sahlin models rather than first-order model. Furthermore, the effect of LA/-CD complexation on the degradation of ISIs was studied through scanning electron microscopy (SEM). Results showed that hydrophilic nature of -CD facilitated the surface erosion of PLGA chains, however after 18 d, ISI-1/10 had still a proper structural strength, due to no hydrolytic degradation of -CD in this implant.
引用
收藏
页码:355 / 364
页数:10
相关论文
共 49 条
[1]   Injectable implants for the sustained release of protein and peptide drugs [J].
Agarwal, Priyanka ;
Rupenthal, Ilva D. .
DRUG DISCOVERY TODAY, 2013, 18 (7-8) :337-349
[2]   Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems [J].
Arifin, Davis Yohanes ;
Lee, Lai Yeng ;
Wang, Chi-Hwa .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (12-13) :1274-1325
[3]   Controlled-Release Carbamazepine Granules and Tablets Comprising Lipophilic and Hydrophilic Matrix Components [J].
Barakat, Nahla S. ;
Elbagory, Ibrahim M. ;
Almurshedi, Alanood S. .
AAPS PHARMSCITECH, 2008, 9 (04) :1054-1062
[4]   Cyclodextrins as pharmaccutical solubilizers [J].
Brewster, Marcus E. ;
Loftsson, Thorsteinn .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :645-666
[5]   Phase inversion dynamics of PLGA solutions related to drug delivery - Part II. The role of solution thermodynamics and bath-side mass transfer [J].
Brodbeck, KJ ;
DesNoyer, JR ;
McHugh, AJ .
JOURNAL OF CONTROLLED RELEASE, 1999, 62 (03) :333-344
[6]   Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles [J].
Budhian, Avinash ;
Siegel, Steven J. ;
Winey, Karen I. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 346 (1-2) :151-159
[7]   Beyond Estrogen: Targeting Gonadotropin Hormones in the Treatment of Alzheimer's Disease [J].
Casadesus, Gemma ;
Zhu, Xiongwei ;
Atwood, Craig S. ;
Webber, Kate M. ;
Perry, George ;
Bowen, Richard L. ;
Smith, Mark A. .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2004, 3 (04) :281-285
[8]  
Gil EC, 2007, AAPS PHARMSCITECH, V8
[9]   Study of inclusion complexes of acridine with β- and (2,6-di-O-methyl)-β-cyclodextrin by use of solubility diagrams and NMR spectroscopy [J].
Correia, I ;
Bezzenine, N ;
Ronzani, N ;
Platzer, N ;
Beloeil, JC ;
Doan, BT .
JOURNAL OF PHYSICAL ORGANIC CHEMISTRY, 2002, 15 (09) :647-659
[10]  
Dash S, 2010, ACTA POL PHARM, V67, P217